FDA approves Convenia RTU ahead of Q3 results for Zoetis stock

Published on 10/29/2026 at 13:37 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Zoetis stock stood at EUR 70.40 on October 29, 2026. Q3 results are scheduled for November 5, 2026 after Q2 revenue of USD 2.47 billion.

Product approval and upcoming results

Convenia RTU can provide up to 14 days of antibiotic treatment from one injection.
Second-quarter 2026 revenue reached USD 2.47 billion, while diluted earnings per share were USD 1.65.
Jefferies cut its Zoetis target from USD 103 to USD 83 on October 20, 2026.

ZTS, US98978V1035, Illustration mit AI erstellt.

Zoetis received U.S. Food and Drug Administration approval for Convenia RTU for Dogs on October 20, 2026, adding a ready-to-use canine antibiotic to its companion-animal portfolio. According to the Zoetis release, the treatment can provide up to 14 days of antibiotic coverage from one injection.

Why the product matters

The approval broadens Zoetis' options for dogs with susceptible bacterial skin infections, including pyoderma, abscesses and wounds. The product is expected to reach veterinarians in the first quarter of 2027, according to the FDA.

Financial pressure remains part of the setup. Zoetis generated USD 2.47 billion of revenue and USD 691.0 million of net income attributable to common shareholders in the second quarter of 2026. Diluted earnings per share were USD 1.65 for that period.

What does the target cut mean?

MarketScreener reported that Jefferies cut its Zoetis target from USD 103 to USD 83 on October 20, 2026, while changing its rating from Buy to Hold. The contrast is clear: the product pipeline is expanding as pricing pressure and competitive risks weigh on expectations.

Three dates shape the setup

Zoetis reported second-quarter revenue of USD 2.47 billion on August 6, 2026, declared a USD 0.53 quarterly dividend on October 8, 2026, and received the Convenia RTU approval on October 20, 2026. The next dates are the October 30, 2026 record date for the dividend and the November 5, 2026 release of third-quarter results, according to the Zoetis release and MarketBeat.

Zoetis stock quote

Zoetis stock was trading at EUR 70.40 at Lang & Schwarz on October 29, 2026 at 1:31 p.m. CEST. The primary listing is on the NYSE, where the quoted currency is USD.

The further course of trading is shown by the continuously updated real-time quote of Zoetis stock.